12:27 M T III Problem 1 Caravac, also known as the Sinovac COVID 19 vaccine, is an inactivated vs COVID-19 vaccine developed by the Calnese compary Sinovac Biotech It was Phase II clinical trialled in Hille, Indones, the Muligpes, and Turkey and relies on tradional echology similar SP-Cory and Cream, her tractivased-vins 120VID-19 varrines. Canavar dos l be and calfe final dexx anal the same for formulating Oma Vacan harpted refrigerated at 2-8 (36-46 F), puns a which flu vacci A real world study of tens of millions of Chicans who received Corona Vac found 65% effective against symptomatic COVID-15, 5% against hospitalization, s against ICU admissions, and 86% and thus In Brazil, her 25% of the popular in Semme, Six halo, v Canavac, perlaminary valts show drains fell by 955, copodizations by 20%, and symptomatics by 90% in Indonesia, mud wield data from 1281290 heddon workers swad 94% Auction against sympatic infection by the satxine, besing results in clinical als Phase results from Turkey Jublished In The Lancer showed an efficacy of % based on 10.21 Jandpants in the trials. Phase Ill results from Bextil previously showed 30.7% efficacy at ning symptomatic infections and 13.7% effective in preventing mild case meeting treatment Efficacy agane sympomat infections need to 67% with an interval of 21 days or more between the dose CommoVac is being used in vaccination campaigns in various countries in Asia, South America Cenal America, and Eastern Europe. By April 2021, Shovac had a production capacity of 2 billion doses a year. It is cimenly being manufactured at several facilities in China, wiped ne manufatum in Brazil in September 2021 and contually in Egypt and Hungary. On June 2021, the World Health Organization (WHO) validated the vaccine for emergency use. Sinovac has signed purchase agreements for 350 milion doses from COVAX. As of July 2021. Corona Vac was the most widely used COVID-19 vaccine in the world, with 943 million doses delivered. The following information was taken from SINOVAC Company's voting records for the year ended December 31, 2021. Increase in raw materials invertory Decrease in fisted goory Raw materials pe Dildo Fatural all P 35,001 35,000 185.000 280,000 There was no works in process inventory at the beginning or end of the year. SINOVAC's 2021 cost of goods sold is. (Show the computadon in cost of sold statement com / 3 > > Save